Naproxen Sodium
- Product NDC
- 43598-059
- 11-digit product format
- 435980059
- Labeler code
- 43598
- Product ID
- 43598-059_7f658fac-fde0-3b5d-f8ad-15dcaf71cdad
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Dr.Reddy's Laboratories Inc
- Application
- ANDA075168
- Marketing category
- ANDA
- Marketing start
- 2021-08-05
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075168-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen Sodium
- Brand name suffix
- Headache Pain Caplets
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NAPROXEN SODIUM | 220 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9TN87S3A3C | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 849574 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 605ca130-88aa-27d5-330c-6d9c95987f1f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-059-52 | Naproxen Sodium Headache Pain Caplets | 225 in 1 BOTTLE | TABLET, COATED | 225 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43598-059 | NAPROXEN SODIUM HEADACHE PAIN CAPLETS (NAPROXEN SODIUM) TABLET, COATED NAPROXEN SODIUM BACK AND MUSCLE PAIN CAPLETS (NAPROXEN SODIUM) TABLET, COATED [DR.REDDY'S LABORATORIES INC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20241203_605ca130-88aa-27d5-330c-6d9c95987f1f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium Caplets | NAPROXEN SODIUM | Dr Reddy's Laboratories Inc | ee0463bc-e939-1ecf-5a86-d045c426fecf | 2025-07-22 | Warnings | 075168 ANDA075168 |
| Naproxen Sodium Headache Pain Caplets | NAPROXEN SODIUM | Dr.Reddy's Laboratories Inc | 605ca130-88aa-27d5-330c-6d9c95987f1f | 2025-07-22 | Warnings | 075168 ANDA075168 43598-059 |
| Naproxen Sodium | NAPROXEN SODIUM | SAM'S WEST INC | 7a87a339-4482-ec9e-3c77-7ccb9cea2c4c | 2025-07-22 | Warnings | 075168 ANDA075168 |
| Naproxen Sodium | NAPROXEN SODIUM | Kroger Company | 30bcf289-0039-f389-73c4-fef3e8861034 | 2025-07-22 | Warnings | 075168 ANDA075168 |
| Naproxen Sodium | NAPROXEN SODIUM | Dr.Reddy's Laboratories Limited | aca5d497-fbc6-464d-2dee-25c50e11bc78 | 2025-06-03 | Warnings | 075168 ANDA075168 |
| Naproxen Sodium Headache Pain | NAPROXEN SODIUM | Dr.Reddy's Laboratories Inc | 12e45b43-eca2-73f4-1d68-07d4238f8c70 | 2025-06-03 | Warnings | 075168 ANDA075168 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 849574 | naproxen sodium 220 MG Oral Tablet | PSN | 605ca130-88aa-27d5-330c-6d9c95987f1f | 6 |
| 849574 | naproxen sodium 220 MG Oral Tablet | SCD | 605ca130-88aa-27d5-330c-6d9c95987f1f | 6 |
| 849574 | naproxen sodium 220 MG (as naproxen 200 MG) Oral Tablet | SY | 605ca130-88aa-27d5-330c-6d9c95987f1f | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 43598-059-52 | 43598005952 | 225 TABLET, COATED in 1 BOTTLE (43598-059-52) | 2021-08-05 | 0000-00-00 | No | No | Current |